MECHANISM OF PHORBOL ESTER-INDUCED LIPID METABOLISM
MECHANISM OF PHORBOL ESTER-INDUCED LIPID METABOLISM
批准号:
3183621
负责人:
Richard N Kolesnick
金额:
$23.88万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-04-01 至 1994-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Disordered signal transduction via the protein kinase C pathway has been
implicated in the development of the neoplastic process. The purpose of
this proposal is to define a potential inhibitory pathway for protein
kinase C. The free sphingoid bases have been shown to antagonize
activation of protein kinase C in vitro and in intact cells. However,
evidence has not been presented to suggest that a pathway involving
sphingolipid metabolism to sphingoid bases serves to inactivate protein
kinase C under physiologic conditions. Recent studies from this
laboratory demonstrated that 1,2-diacylglycerols, the endogenous
activators of protein kinase C, stimulated degradation of the
sphingolipid sphingomyelin in GH3 pituitary cells. This event occurred
via a sphingomyelinase (EC 3.1.4.12). Phorbol esters, the tumor-
promoting activators of protein kinase C, failed to stimulate this
event. Further, sphingomyelinase action was sufficient to inactivate
protein kinase C. These studies suggest that 1,2-diacylglycerols may
activate a negative effector pathway for protein kinase C not utilized
by the phorbol esters. The intention of this proposal is to explore
this concept in detail.
Three distinct cell lines will be utilized for these studies; GH3 rat
pituitary cells, 3T3 mouse fibroblasts and HL-60, human leukemia cells.
The effect of 1,2-diacylglycerols and phorbol esters on the synthesis
and degradation of the choline-containing phospholipids,
phosphatidylcholine and sphingomyelin, will be evaluated. The role of
the cAMP and protein kinase C systems in these processes will be
determined. Sphingomyelin degradation via a spingomyelinase will be
related to protein kinase C activation/inactivation. Receptor-mediated
sphingomyelinase activation and the generation of free sphingoid bases
will be assessed for ligands that utilize the phosphoinositide pathway
for signal transduction. Studies will be performed to determine if
differences in the pattern of biologic responses after 1,2-
diacylglycerols and phorbol esters can be ascribed to sphingomyelinase
action. Hopefully, these studies will reveal a physiologically relevant
inhibitory pathway for protein kinase C and explain some of the
differences observed between cellular activation by 1,2-diacylglycerols
and phorbol esters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
-
批准号:10323269
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2021
-
负责人:Richard N Kolesnick
-
依托单位:
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
-
批准号:10543438
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2021
-
负责人:Richard N Kolesnick
-
依托单位:
Patient-derived organoids reveal rectal cancers develop radiosensitivity
-
批准号:10343663
-
项目类别:
-
资助金额:$24.33万
-
财政年份:2021
-
负责人:Richard N Kolesnick
-
依托单位:
Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome
-
批准号:9981619
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2017
-
负责人:Richard N Kolesnick
-
依托单位:
Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome
-
批准号:9385453
-
项目类别:
-
资助金额:$60.48万
-
财政年份:2017
-
负责人:Richard N Kolesnick
-
依托单位:
Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome
-
批准号:10213610
-
项目类别:
-
资助金额:$58.38万
-
财政年份:2017
-
负责人:Richard N Kolesnick
-
依托单位:
C16-Ceramide Nano-Liposomes Reverse Multi-Drug Resistance
-
批准号:9921301
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2016
-
负责人:Richard N Kolesnick
-
依托单位:
Sphingolipid-Based Anti-Angiogenic Chemosensitization
-
批准号:9274265
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2016
-
负责人:Richard N Kolesnick
-
依托单位:
Sphingolipid-Based Anti-Angiogenic Chemosensitization
-
批准号:9101093
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2016
-
负责人:Richard N Kolesnick
-
依托单位:
C16-Ceramide Nano-Liposomes Reverse Multi-Drug Resistance
-
批准号:9106835
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2016
-
负责人:Richard N Kolesnick
-
依托单位:
Re-setting the Endothelial Ceramide Rheostat
-
批准号:8451274
-
项目类别:
-
资助金额:$35.67万
-
财政年份:2012
-
负责人:Richard N Kolesnick
-
依托单位:
Re-setting the Endothelial Ceramide Rheostat
-
批准号:8636408
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2012
-
负责人:Richard N Kolesnick
-
依托单位:
Re-setting the Endothelial Ceramide Rheostat
-
批准号:8297312
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2012
-
负责人:Richard N Kolesnick
-
依托单位:
Modulation of Ceramide Induced Apoptosis in Vivo
-
批准号:7057789
-
项目类别:
-
资助金额:$36.78万
-
财政年份:2000
-
负责人:Richard N Kolesnick
-
依托单位:
MODULATION OF CERAMIDE INDUCED APOPTOSIS IN VIVO
-
批准号:6362751
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2000
-
负责人:Richard N Kolesnick
-
依托单位:
MODULATION OF CERAMIDE INDUCED APOPTOSIS IN VIVO
-
批准号:6514439
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2000
-
负责人:Richard N Kolesnick
-
依托单位:
Modulation of Ceramide Induced Apoptosis in Vivo
-
批准号:6921560
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2000
-
负责人:Richard N Kolesnick
-
依托单位:
MODULATION OF CERAMIDE INDUCED APOPTOSIS IN VIVO
-
批准号:6633672
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2000
-
负责人:Richard N Kolesnick
-
依托单位:
Modulation of Ceramide Induced Apoptosis in Vivo
-
批准号:7185072
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2000
-
负责人:Richard N Kolesnick
-
依托单位:
MODULATION OF CERAMIDE INDUCED APOPTOSIS IN VIVO
-
批准号:6698023
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2000
-
负责人:Richard N Kolesnick
-
依托单位:
海外基金